• Strategy
  • Payers
  • AI
  • Cybersecurity
  • Device Development
  • Studies/Published Research
  • Ethics
  • Regulatory
  • Digital Biomarkers
  • Data Science
  • Companion Diagnostics
  • Clinical Care
  • Digital Therapeutics
  • Academic Research
  • Virtual Reality
  • RWE
  • Digital Endpoints
  • Medical Devices (Class II and Class III)
  • Commercialization
  • Clinical Trials
  • Drug-Device Combinations
  • SaMD
  • Remote Patient Monitoring
  • Patient Engagement
  • Profiles/Q&A

Astorg Acquires Majority Interest in Avania

Article

Avania announced that Astorg has acquired a majority stake in the company, which will actively support management’s plans to advance Avaina’s development as MedTech solution provider. Astorg has an extensive global network of relationships in the MedTech space which will aid to strengthen Avania’s pipeline and broaden their customer base all while capital access accelerating its growth. The platform will assist Avania to try to be ahead of the MedTech CRO space and will bring additional investments to the infrastructure.

Read more about this news release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.